PFOA, C8 studies, and corporate disclosure

The claim

Claim: manufacturer concealed PFOA contamination and risks. Internal records and independent studies support exposure and company knowledge in specific cases. This file tests the narrow allegation rather than treating secrecy, coincidence, or public controversy as evidence by themselves.

Chronology

DuPont used PFOA for decades near Parkersburg; litigation disclosed records and a panel studied exposed residents. Chronology helps separate contemporaneous knowledge from later interpretation; sequence alone cannot establish a causal relationship.

Primary record and data

Court records, EPA material, biomonitoring, and C8 Science Panel reports establish contamination; findings are disease-specific. Original records establish what was measured or decided, while independent work is needed to test methods and institutional conclusions.

Independent scientific evidence

PFOA persists in water and bodies; panel reported probable links for selected outcomes, not every illness. Convergent observations and a plausible mechanism carry more weight than a single image, anecdote, or disputed quotation.

Alternative explanations

Exposure, confounding, and latency complicate individual attribution; “probable link” is not personal causation. A strong alternative must explain the observations and remain open to disconfirmation; ordinary causes deserve the same scrutiny as extraordinary ones.

Limitations and uncertainty

Historical exposure and health records are incomplete and uneven; causal attribution, corporate knowledge, and intent are separate questions requiring separate evidence. Uncertainty is stated explicitly rather than treated as support for the strongest version of a claim.

Calibrated verdict

Contamination and corporate knowledge are documented; claims should remain compound- and outcome-specific. Documented research, emissions, negligence, or secrecy should not be conflated with a broader unsupported coordinated plot.

Testable evidence requirements

Compare reports, discharges, water, cohorts, and independent dose-response replications. A persuasive claim specifies what new evidence would change the assessment and allows independent replication, including negative results.

Sources and source limits

1. C8 Science Panel, Probable LinksIndependent, outcome-specific findings; not individual causation.
2. U.S. EPA, PFOA/PFOSRegulatory assessments and evolving evidence.
3. Grandjean & Clapp, PFAS Health RisksPeer-reviewed health review.